Arnhold LLC Johnson & Johnson Transaction History

Arnhold LLC

$909 Million
Q2 2024

A detailed history of Arnhold LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Arnhold LLC holds 11,150 shares of JNJ stock, worth $1.79 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

11,150

Previous 11,150 -0.0%

Holding current value

$1.79 Million

Previous $1.76 Million 7.6%

% of portfolio

0.18%

Previous 0.19%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$155.22 - $162.74 $168,413 - $176,572	-1,085 Reduced 8.87%	11,150 $1.76 Million
Q3 2023 Oct 24, 2023	SELL	$155.75 - $174.48 $93,294 - $104,513	-599 Reduced 4.67%	12,235 $1.91 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $203,917 - $243,351	-1,350 Reduced 9.52%	12,834 $1.99 Million
Q4 2022 Feb 07, 2023	SELL	$160.2 - $179.79 $1.68 Million - $1.89 Million	-10,488 Reduced 42.51%	14,184 $2.51 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $46,651 - $52,979	-295 Reduced 1.18%	24,672 $4.37 Million
Q3 2021 Oct 19, 2021	SELL	$161.5 - $179.47 $97,707 - $108,579	-605 Reduced 2.37%	24,967 $4.03 Million
Q2 2019 Aug 08, 2019	SELL	$131.15 - $144.24 $5.77 Million - $6.35 Million	-44,006 Reduced 63.25%	25,572 $3.56 Million
Q1 2019 May 09, 2019	SELL	$125.72 - $139.79 $37,087 - $41,238	-295 Reduced 0.42%	69,578 $9.73 Million
Q4 2018 Feb 08, 2019	BUY	$122.84 - $147.84 $183,645 - $221,020	1,495 Added 2.19%	69,873 $9.02 Million
Q3 2018 Nov 06, 2018	SELL	$121.58 - $142.88 $654,829 - $769,551	-5,386 Reduced 7.3%	68,378 $9.45 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $2.1 Million - $2.32 Million	17,622 Added 31.39%	73,764 $8.95 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $7.02 Million - $8.32 Million	56,142 New	56,142 $7.2 Million

Others Institutions Holding JNJ

# of Institutions

4,218

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arnhold LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arnhold LLC with notifications on news.

Account